TGFB1 and Myocardial fibrosis: Meng et al. found that APN-modified bone marrow mesenchymal stem cells (BMSCs) could reduce TGF-β1/smad expression and thus suppress myocardial fibrosis in diabetic rats and HG-induced H9C2 cells [23].